{
    "id": 1016,
    "fullName": "MET V1238I",
    "impact": "missense",
    "proteinEffect": "gain of function",
    "geneVariantDescriptions": [
        {
            "description": "MET V1238I (corresponds to V1220I) lies within the protein kinase domain and RANBP9-interacting region of the Met protein (UniProt.org). V1238I confers a gain of function to Met, resulting in increased Met phosphorylation in cell culture and promotes tumor formation in mice (PMID: 19783361, PMID: 9326629).",
            "references": [
                {
                    "id": 295,
                    "pubMedId": null,
                    "title": null,
                    "url": "https://www.uniprot.org"
                },
                {
                    "id": 455,
                    "pubMedId": 19783361,
                    "title": "Differential inhibition sensitivities of MET mutants to the small molecule inhibitor SU11274.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19783361"
                },
                {
                    "id": 2199,
                    "pubMedId": 9326629,
                    "title": "Activating mutations for the met tyrosine kinase receptor in human cancer.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/9326629"
                }
            ]
        }
    ],
    "type": null,
    "gene": {
        "id": 4233,
        "geneSymbol": "MET",
        "terms": [
            "MET",
            "AUTS9",
            "c-Met",
            "DFNB97",
            "HGFR",
            "RCCP2"
        ]
    },
    "variant": "V1238I",
    "createDate": "07/17/2014",
    "updateDate": "05/12/2018",
    "referenceTranscriptCoordinates": {
        "id": 144942,
        "transcript": "NM_001127500",
        "gDna": "chr7:g.116783329G>A",
        "cDna": "c.3712G>A",
        "protein": "p.V1238I",
        "sourceDb": "RefSeq",
        "refGenomeBuild": "GRCh38/hg38"
    },
    "partnerGenes": [
        
    ],
    "evidence": [
        {
            "id": 814,
            "approvalStatus": "Preclinical",
            "evidenceType": "Actionable",
            "efficacyEvidence": "In a preclinical study, a cell line expressing MET V1238I demonstrated sensitivity to SU11274 treatment (PMID: 19783361).",
            "molecularProfile": {
                "id": 1124,
                "profileName": "MET V1238I"
            },
            "therapy": {
                "id": 1089,
                "therapyName": "SU11274",
                "synonyms": null
            },
            "indication": {
                "id": 162,
                "name": "cancer",
                "source": "DOID"
            },
            "responseType": "sensitive",
            "references": [
                {
                    "id": 455,
                    "pubMedId": 19783361,
                    "title": "Differential inhibition sensitivities of MET mutants to the small molecule inhibitor SU11274.",
                    "url": "http://www.ncbi.nlm.nih.gov/pubmed/19783361"
                }
            ],
            "ampCapAscoEvidenceLevel": "D",
            "ampCapAscoInferredTier": "II"
        }
    ],
    "molecularProfiles": [
        {
            "id": 1124,
            "profileName": "MET V1238I",
            "profileTreatmentApproaches": [
                {
                    "id": 1517,
                    "name": "MET Inhibitor",
                    "profileName": "MET V1238I"
                }
            ]
        }
    ],
    "allTranscriptCoordinates": [
        {
            "id": 144942,
            "transcript": "NM_001127500",
            "gDna": "chr7:g.116783329G>A",
            "cDna": "c.3712G>A",
            "protein": "p.V1238I",
            "sourceDb": "RefSeq",
            "refGenomeBuild": "GRCh38/hg38"
        }
    ]
}